Sanofi CEO Hudson singles out his digital ambitions in big executive shakeup | Fierce Pharma
Sanofi improves workforce insights with real-time data across the globe.
Regulators OK restart LentiVector delivered eye drug trials
Unable to 'align' with FDA, Regeneron, Sanofi pull application for Libtayo in cervical cancer days before decision date | Fierce Pharma
MannKind tanks as Sanofi pulls plug on inhaled insulin deal
Sanofi stock falls as breast cancer drug amcenestrant development stopped as trial fails | Seeking Alpha
Sanofi, Regeneron's Praluent pulls off PCSK9 coup with 29% cut to death risks in most vulnerable patients | Fierce Pharma
Over-the-counter heartburn drug Zantac pulled in US, Canada | WPBN
Stocks To Watch: Sanofi Sees Relative Strength Rating Jump To 83 | Investor's Business Daily
Sanofi, Maker of World's Top-Selling Insulin, to Exit Diabetes Research - WSJ
Sanofi Microbiosys Digestive Comfort 30 capsules - Walmart.com
Sanofi pulls heartburn drug Zantac from U.S. shelves - STAT
Sanofi pulls out of Zika vaccine collaboration as feds gut its R&D contract | Fierce Pharma
ConAgra, Roche, Sanofi-Aventis and RadioShack Pull Advertisements from Fox News Channel's Glenn Beck | Color Of Change
Sanofi to pull the plug on mRNA Covid-19 vaccine after rivals' success
Sanofi raises profit forecast following positive Q2 results - PMLiVE
Sanofi abandoning Auvi-Q after dosage problems led to total recall
Dupixent continues to grow with new US indication
Zantac Recall Widens as Sanofi Pulls Its Drug Over Carcinogen Fears - The New York Times
Sanofi pulls phase 3 trial of $3.7B drug as competition heats up
